Rankings
Pricing
Log In
Free Trial
US-listed companies
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc.
AMLX
Market cap
$194.45M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2022
Product revenue, net
22
Cost of sales
3
Research and development
93
Selling, general and administrative
127
Total operating expenses
224
Loss from operations
-201
Interest income
4
Other expense, net
-1
Total other income (expense), net
4
Loss before income taxes
-198
Provision for income taxes
1
Net loss
-198
Earnings Per Share, Basic
-3.39
Earnings Per Share, Diluted
-3.39